These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23026080)

  • 1. Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.
    Dosa S; Stirnberg M; Lülsdorff V; Häußler D; Maurer E; Gütschow M
    Bioorg Med Chem; 2012 Nov; 20(21):6489-505. PubMed ID: 23026080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
    Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
    Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
    ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the first low-molecular-weight inhibitors of matriptase-2.
    Sisay MT; Steinmetzer T; Stirnberg M; Maurer E; Hammami M; Bajorath J; Gütschow M
    J Med Chem; 2010 Aug; 53(15):5523-35. PubMed ID: 20684597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
    Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
    Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
    Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
    Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors.
    Maiwald A; Hammami M; Wagner S; Heine A; Klebe G; Steinmetzer T
    J Enzyme Inhib Med Chem; 2016; 31(sup1):89-97. PubMed ID: 27168215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limiting the Number of Potential Binding Modes by Introducing Symmetry into Ligands: Structure-Based Design of Inhibitors for Trypsin-Like Serine Proteases.
    Furtmann N; Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Bajorath J; Gütschow M
    Chemistry; 2016 Jan; 22(2):610-25. PubMed ID: 26625703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase.
    Enyedy IJ; Lee SL; Kuo AH; Dickson RB; Lin CY; Wang S
    J Med Chem; 2001 Apr; 44(9):1349-55. PubMed ID: 11311057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive study on the mechanism of inhibition of serine proteases by benzamidines based on quantitative structure-activity relationship studies.
    Gupta SP; Handa A; Shewade DG
    Arzneimittelforschung; 1987 Jan; 37(1):47-50. PubMed ID: 2952126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of large-to-small surfactant aggregate conversion by serine protease inhibitors of the bis-benzamidine type.
    Ruppert C; Pucker C; Markart P; Schmidt R; Grimminger F; Seeger W; Stürzebecher J; Günther A
    Am J Respir Cell Mol Biol; 2003 Jan; 28(1):95-102. PubMed ID: 12495937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study.
    Casale E; Collyer C; Ascenzi P; Balliano G; Milla P; Viola F; Fasano M; Menegatti E; Bolognesi M
    Biophys Chem; 1995 Mar; 54(1):75-81. PubMed ID: 7703351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
    Kyrieleis OJ; Huber R; Ong E; Oehler R; Hunter M; Madison EL; Jacob U
    FEBS J; 2007 Apr; 274(8):2148-60. PubMed ID: 17388811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
    Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
    Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxyanion-mediated inhibition of serine proteases.
    Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
    Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.